What topics does this cannabis study cover?

This study covers research on: Mental Health, Neuroprotection.

Where was this research published?

Published in bioRxiv : the preprint server for biology on July 20, 2026.

Prenatal cannabis exposure disrupts fetal brain development

Q: What did this research study find?

Prenatal cannabis exposure produced **minimal molecular effects in female first-trimester fetal brains** but pronounced disruption in male second-trimester brains.

Prenatal cannabis exposure affects human fetal neurodevelopment: an integrated multi-omics study.

bioRxiv : the preprint server for biology • July 20, 2026 • Highly Relevant

🤖

AI Summary

This study examined human fetal brain tissue from pregnancies with and without documented maternal cannabis exposure, using an integrated multi-omics approach that combined transcriptomics and global proteomics. The abstract reports that prenatal cannabis exposure had minimal molecular effects in female first-trimester brains but caused pronounced, system-level disruption in male second-trimester brains, suggesting that timing and fetal sex may influence vulnerability.

The affected biological pathways carried molecular signatures associated with neurodevelopmental and neuropsychiatric conditions, including autism spectrum disorder, schizophrenia-related pathology, and problems involving cortical connectivity. These findings raise significant concerns about cannabis use during pregnancy, although the study identifies molecular associations rather than proving that exposure directly causes those later conditions. The abstract does not provide sample sizes, effect sizes, or percentages.

💡 Key Findings

Prenatal cannabis exposure produced minimal molecular effects in female first-trimester fetal brains but pronounced disruption in male second-trimester brains.

Good

70%

Exposure disrupted biological pathways with molecular signatures linked to autism spectrum disorder, schizophrenia-related pathology, and impaired cortical connectivity.

Good

70%

The findings raise significant concerns about cannabis use during pregnancy, while the abstract does not establish that exposure directly causes later neurodevelopmental disorders.

High

80%

📄 Original Abstract

Prenatal cannabis use is on the rise, and observational studies suggest that such use results in neurodevelopmental deficits in the offspring. Because observational studies can be confounded by unaccounted factors, we studied the neurodevelopmental consequences, at the molecular level, of prenatal cannabis use. We applied an integrated multi-omics approach, combining transcriptomics and global proteomics, to first trimester (T1) and second trimester (T2) human fetal brains from pregnancies with and without documented maternal cannabis exposure and no use of drugs of abuse. Prenatal cannabis exposure produced minimal molecular effects in female T1 fetal brains but induced pronounced system-level disruption in male T2 fetal brains. These disrupted pathways have molecular signatures linked to neurodevelopmental and neuropsychiatric disorders, including autism spectrum disorder, schizophrenia-related pathology, and disorders of cortical connectivity, raising significant concerns of prenatal cannabis use.

Paper Type

📄 Research

Publication

Journal: bioRxiv : the preprint server for biology
Published: July 20, 2026
PMID: 42539194
DOI: 10.64898/2026.07.15.738779

Authors (10)

Guenther Kahlert Department of Pharmaceutics, School of Pharmacy, University of Washington; Seattle, Washington 98195, USA.
Xin Chen Department of Pharmaceutics, School of Pharmacy, University of Washington; Seattle, Washington 98195, USA.
Theo K Bammler Department of Environmental and Occupational Health Sciences, University of Washington; Seattle, Washington 98195, USA.
James W MacDonald Department of Environmental and Occupational Health Sciences, University of Washington; Seattle, Washington 98195, USA.
Lyndsey S Benson Department of Obstetrics and Gynecology, University of Washington School of Medicine; Seattle, Washington 98195, USA.
+5 more authors